Onida, F, Sbianchi, G, Radujkovic, A, Sockel, K, Kroger, N, Sierra, J, Socie, G, Cornelissen, J, Poire, X, Raida, L, Bourhis, JH, Finke, J, Passweg, J, Salmenniemi, U, Schouten, HC, Beguin, Y, Martin, S, Deconinck, E, Ganser, A, Zver, S, Lioure, B, Rohini, R, Koster, L, Hayden, P, Iacobelli, S, Robin, M, Yakoub-Agha, I. Prognostic value of a new clinically-based classification system in patients with CMML undergoing allogeneic HCT: a retrospective analysis of the EBMT-CMWP. BONE MARROW TRANSPLANTATION. 2022; 57(6)DOI:10.1038/s41409-021-01555-9. PMID:35352038. IF:4.800(Q1/2D).

González-Muñoza C, Briones J, Sang Park H, García-Planella E. Marginal zone lymphoma under anti-TNF treatment in Crohn disease. Gastroenterologia y Hepatologia. 2022; 45(5)DOI:10.1016/j.gastrohep.2021.05.010. PMID:34118314. IF:1.900(Q4/10D).

Serna, N, Pallares, V, Unzueta, U, Garcia-Leon, A, Volta-Duran, E, Sanchez-Chardi, A, Parlade, E, Rueda, A, Casanova, I, Falgas, A, Alba-Castellon, L, Sierra, J, Villaverde, A, Vazquez, E, Mangues, R. Engineering non-antibody human proteins as efficient scaffolds for selective, receptor-targeted drug delivery. JOURNAL OF CONTROLLED RELEASE. 2022; 343DOI:10.1016/j.jconrel.2022.01.017. PMID:35051493. IF:10.800(Q1/1D).

Bataller, A, Garrido, A, Guijarro, F, Onate, G, Diaz-Beya, M, Arnan, M, Tormo, M, Vives, S, de Llano, MPQ, Coll, R, Gallardo, D, Vall-Llovera, F, Escoda, L, Garcia-Guinon, A, Salamero, O, Sampol, A, Merchan, BM, Bargay, J, Castano-Diez, S, Esteban, D, Oliver-Caldes, A, Rivero, A, Mozas, P, Lopez-Guerra, M, Pratcorona, M, Zamora, L, Costa, D, Rozman, M, Nomdedeu, JF, Colomer, D, Brunet, S, Sierra, J, Esteve, J. European LeukemiaNet 2017 risk stratification for acute myeloid leukemia: validation in a risk-adapted protocol. Blood Advances. 2022; 6(4)DOI:10.1182/bloodadvances.2021005585. PMID:34911079. IF:7.500(Q1/2D).